Twice-daily baths followed by occlusive moisturizer led to greater improvement.
From the Journals
After 11 months, treatment with sodium zirconium cyclosilicate successfully controlled serum potassium.
U.S. Supreme Court Justices heard oral arguments Dec. 10 in a case that centers on whether the federal government owes insurers billions based on...
Boston Scientific anticipates early 2020 launch.
ORLANDO – A phase 2/3 study is planned to assess the gene therapy in a larger group of patients with sickle cell disease.
The Food and Drug Administration’s decision on reduction of events in high-risk patients was based primarily on the REDUCE-IT trial results.
When Melissa Gonzalez excitedly tweeted that she had been accepted to medical school earlier this year, she had no idea the tweet would draw...
NEW ORLEANS – In Dr. Raffalli’s clinical experience, cyberbullying has become the bully’s weapon of choice.
News from the FDA/CDC
Unusual early spike related to increased influenza B activity, CDC says.
The move sets up criteria and requirements for future devices of the same type.
ORLANDO – ASH has released the first of five new sets of sickle cell disease guidelines, with the first focusing on screening and management of...